These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 8977630

  • 1. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES, Batchelor KW, Habib FK.
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [Abstract] [Full Text] [Related]

  • 2. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE, Shu WP, Kirschenbaum A, Levine AC, Miniati DN, Liu BC.
    Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

  • 5. Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
    Maria McCrohan A, Morrissey C, O'Keane C, Mulligan N, Watson C, Smith J, Fitzpatrick JM, Watson RW.
    Cancer; 2006 Jun 15; 106(12):2743-52. PubMed ID: 16703599
    [Abstract] [Full Text] [Related]

  • 6. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 15; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D.
    J Cell Physiol; 1998 May 15; 175(2):184-92. PubMed ID: 9525477
    [Abstract] [Full Text] [Related]

  • 9. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.
    Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Jul 01; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 12. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW.
    Prostate; 2007 May 15; 67(7):722-31. PubMed ID: 17342749
    [Abstract] [Full Text] [Related]

  • 13. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I, Nelson PS, Carroll JM, Roberts CT, Ware JL.
    Prostate; 2004 Nov 01; 61(3):276-90. PubMed ID: 15368471
    [Abstract] [Full Text] [Related]

  • 14. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G.
    Cancer Res; 1997 Mar 15; 57(6):1086-90. PubMed ID: 9067276
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
    Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H.
    Cancer Gene Ther; 2000 Jul 15; 7(7):997-1007. PubMed ID: 10917202
    [Abstract] [Full Text] [Related]

  • 16. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H.
    Cancer Detect Prev; 1996 Jul 15; 20(1):68-75. PubMed ID: 8907206
    [Abstract] [Full Text] [Related]

  • 17. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H.
    Br J Cancer; 1999 Sep 15; 81(2):242-51. PubMed ID: 10496349
    [Abstract] [Full Text] [Related]

  • 18. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME.
    Prostate; 2006 Jun 01; 66(8):886-94. PubMed ID: 16496412
    [Abstract] [Full Text] [Related]

  • 19. Androgen receptor-mediated repression of novel target genes.
    Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA.
    Prostate; 2007 Sep 15; 67(13):1371-83. PubMed ID: 17624924
    [Abstract] [Full Text] [Related]

  • 20. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.